Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Buyer: | University College London Hospitals NHS FT |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £816,000 |
| Release Date: | 19 February 2025 |
| Application Deadline: | 26 March 2025 |
| Procurement ID (OCID): | ocds-h6vhtk-04e3d2 |
| Notice Reference: | 005785-2025 |
Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.
Document pack· 1 file
Published contracts in the last 12 months
28
total contracts
£176.5m
total value
£29,414,167
average contract size
Typical categories
UCLH-7264 - Non-Emergency Patient Transport Services
University College London Hospitals NHS FT · WAC-579054
UCLH-7264 - Non-Emergency Patient Transport Services
University College London Hospitals NHS FT · WAC-578351
UCLH-5600 - Proton Beam Therapy and Radiotherapy Patient Accomodation
University College London Hospitals NHS FT · WAC-552107
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
26 March 2025
Closed
Estimated Value
£816,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →